We found that ALIX protein expression, especially combined with serum CA199, had great potentials in differentiating PC patients at stage I/II from stage III/IV, as well as distinguishing PC from other pancreatic diseases. The gene discussed is PDCD6IP; the disease is pachyonychia congenita.